| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.967 | 39.263 | 36.270 | 56.080 | 59.306 | 156.257 | 29.922 | 10.994 | 26.561 | 49.635 |
| Total Income - EUR | 37.970 | 39.267 | 36.273 | 56.082 | 59.309 | 156.449 | 44.709 | 10.995 | 26.313 | 49.633 |
| Total Expenses - EUR | 35.128 | 37.573 | 32.892 | 49.765 | 51.165 | 129.378 | 43.580 | 23.673 | 20.475 | 44.906 |
| Gross Profit/Loss - EUR | 2.842 | 1.694 | 3.381 | 6.317 | 8.145 | 27.071 | 1.129 | -12.677 | 5.837 | 4.727 |
| Net Profit/Loss - EUR | 1.703 | 909 | 2.713 | 5.756 | 7.552 | 25.620 | 735 | -12.776 | 5.588 | 4.291 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Crismed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 8.332 | 5.593 | 2.945 | 422 | 0 | 0 |
| Current Assets | 18.714 | 22.232 | 27.235 | 33.755 | 44.906 | 74.266 | 51.375 | 40.944 | 48.713 | 57.940 |
| Inventories | 2.519 | 2.983 | 7.959 | 8.095 | 14.763 | 12.747 | 20.783 | 15.855 | 23.838 | 20.627 |
| Receivables | 7.405 | 5.777 | 11.750 | 12.290 | 23.667 | 5.765 | 7.422 | 2.838 | 9.852 | 20.540 |
| Cash | 8.790 | 13.472 | 7.525 | 13.370 | 6.476 | 55.754 | 23.170 | 22.251 | 15.023 | 16.773 |
| Shareholders Funds | 11.596 | 12.387 | 14.890 | 20.372 | 27.530 | 52.628 | 52.196 | 39.582 | 45.049 | 49.088 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.192 | 9.899 | 12.372 | 13.500 | 25.748 | 27.325 | 2.219 | 1.887 | 3.750 | 8.969 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Crismed S.r.l.